The Director General of Nigeria Institute of Medical Research (NIMR), Professor Babatunde Salako, on Monday, July 25, stated that it had found a new Malaria vector known as anopheles stephensi in the northern Nigerian region.
Salako said that it was a rugged vector, which is quite tough to eliminate and had not been found anywhere near West Africa.
He stated that this was found by researchers of NIMR, which had implications for the control of malaria in Nigeria.
Salako stated that the NIMR was presently looking at vaccines.
“We have done many studies on vaccines and are now looking at vaccine development.
“We are currently working with five groups in a consortium to make world local vaccines in Nigeria which was distinguishable from production,” he said.
Salako stated that the mere idea was to assure that researchers in Nigeria could take it from the start to the end of the vaccine development process.
He stated that if any new epidemic or disease, unknown or known, it would be possible for Nigeria to make its own vaccine tomorrow.
He also added that NIMR was also looking at the efficacy, side effects as well as responsiveness of the human body to coronavirus vaccines.
He stated that the institute is looking at three different COVID vaccines, and 2000 people in Nigeria would be tested to find whether the vaccines evoked response among Nigerians or not.
Earlier, a Senior Researcher, Samuel Amao, stated that the event was unprecedented.
Amao stated that the institute is dealing with somebody who is a game changer so brilliant that one doesn’t require to voice it.
He stated that Salako was a leader who did not just tell you how to do it and also demonstrated to you the same.
He stated that the NIMR was a place where aspiring researchers are supposed to be.